Akzo Nobel/€AKZA
1D1W1MYTD1Y5YMAX
Capital at risk
About Akzo Nobel
Akzo Nobel is a global company headquartered in Amsterdam, Netherlands, specializing in the production of paints and coatings. Its core business operations include decorative paints and performance coatings, serving industries such as automotive, construction, and consumer goods. The company has a significant international presence, operating in numerous countries around the world. Akzo Nobel is known for its strong commitment to innovation and sustainability, aiming to create high-performance products with a reduced environmental impact. With a history dating back to 1792, Akzo Nobel has built a reputation for quality and reliability in its product offerings.
- Ticker
- €AKZA
- Sector
- Materials
- Primary listing
- AEX
- Employees
- 30,900
- Headquarters
- Amsterdam, Netherlands
- Website
- www.akzonobel.com
Akzo Nobel Metrics
BasicAdvanced
€9.7B
15.30
€3.71
1.18
€1.98
3.49%
Price and volume
Market cap
€9.7B
Beta
1.18
52-week high
€66.32
52-week low
€46.25
Average daily volume
452K
Dividend rate
€1.98
Financial strength
Current ratio
1.884
Quick ratio
1.477
Long term debt to equity
1.093
Total debt to equity
1.31
Dividend payout ratio (TTM)
52.83%
Interest coverage (TTM)
3.53%
Profitability
EBITDA (TTM)
1,068
Gross margin (TTM)
40.29%
Net profit margin (TTM)
6.43%
Operating margin (TTM)
8.03%
Effective tax rate (TTM)
34.32%
Revenue per employee (TTM)
€320,000
Management effectiveness
Return on assets (TTM)
3.28%
Return on equity (TTM)
14.14%
Valuation
Price to earnings (TTM)
15.3
Price to revenue (TTM)
0.981
Price to book
2
Price to tangible book (TTM)
9.78
Price to free cash flow (TTM)
16.423
Free cash flow yield (TTM)
6.09%
Free cash flow per share (TTM)
3.452
Dividend yield (TTM)
3.49%
Growth
Revenue change (TTM)
-6.00%
Earnings per share change (TTM)
53.89%
3-year revenue growth (CAGR)
-3.08%
10-year revenue growth (CAGR)
-3.72%
3-year earnings per share growth (CAGR)
28.15%
10-year earnings per share growth (CAGR)
-2.27%
3-year dividend per share growth (CAGR)
-8.04%
10-year dividend per share growth (CAGR)
-3.33%
What the Analysts think about Akzo Nobel
Analyst ratings (Buy, Hold, Sell) for Akzo Nobel stock.
Analyst projections of the future price of Akzo Nobel stock.
Bulls say / Bears say
Q2 2026 showed continued operational improvement: organic sales rose 2%, operating income increased to €251 million from €214 million, and adjusted EBITDA margin expanded to 15.4%; management also expects full-year adjusted EBITDA of at least €1.47 billion. (AkzoNobel)
Shareholders of both AkzoNobel and Axalta approved the proposed all-stock merger, materially reducing transaction uncertainty and positioning the companies to pursue greater scale, complementary portfolios and potential synergies once regulatory approvals are secured. (AkzoNobel)
AkzoNobel reached its 2030 target of cutting Scope 1 and 2 emissions by 50% four years early, strengthening its sustainability credentials and potentially supporting customer wins in coatings markets where lower-carbon products are increasingly valued. (AkzoNobel)
First-half 2026 organic sales were flat and reported revenue fell 5% because of adverse currency effects, while Reuters noted weak end markets; this limits near-term top-line momentum despite pricing gains. (Reuters)
The Axalta merger still requires regulatory approvals and closing conditions, with AkzoNobel explicitly flagging integration, synergy-delivery, management-distraction and credit-rating risks. (AkzoNobel)
AkzoNobel’s Russian subsidiaries were placed under temporary external administration in July 2026, creating geopolitical, legal and asset-control uncertainty even though Russia represents less than 2% of group revenue. (AkzoNobel)
Data summarised monthly by Lightyear AI. Last updated on 9 Sept 2026.
Akzo Nobel Financial Performance
Revenues and expenses
Akzo Nobel Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Akzo Nobel
AllEURGBPUSD
Fund name | Fund size | €AKZA weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €104M | 4.50% |
iShares EURO STOXX Mid€DJMC | €572M | 1.19% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 1.19% |
iShares AEX€IAEX | €778M | 0.88% |
iShares AEX£IAEX | £668M | 0.88% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.